Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000230822

Medchemexpress LLC 7-ethyl-4-[3-(4-ethylsulfonyl-2-methoxyphenyl)-4-fluorophenyl]imidazo[4,5-c]pyridazine | 1614245-70-3 | 99.3% | 100 MG
SDP

Supplier:  Medchemexpress LLC HY120874100MG

Encompass_Preferred

Darigabat is an orally active, subtype-selective GABAA positive allosteric modulator (PAM) used in preclinical and research studies to investigate GABAA receptor pharmacology, anxiolytic effects, and anticonvulsant potential.

  • Subtype-selective GABAA PAM targeting α2/α3/α5 subunits.
  • High purity (99.3%) suitable for research applications.
  • Blood-brain barrier penetrant with demonstrated anxiolytic activity in models.
  • Available as solid or DMSO solution; multiple package sizes offered.
  • Useful for pharmacology, pain, anxiety, and epilepsy research.

Catalog No. 50-002-30822


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.